Home
Co-Diagnostics

Co-Diagnostics Market Share Analysis for May 2026

The Co-Dx™ COVID-19 PCR test kit for reliable results in around 30 minutes. Designed with a simple workflow, enabling the test to be run almost anywhere.

Industry: N/A

Domainco-dx.com

Year Founded2013

Employees51 - 200

Annual Revenue--

Co-Diagnostics

Co-Diagnostics (including company regionals)

co-dx.com

See more website traffic and engagement information

Total visits to Co-Diagnostics's top domains

Understand Co-Diagnostics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

co-dx.com6.2K

See more with Sales Intelligence

Avg. visit duration in Co-Diagnostics's top domains

Analyze Co-Diagnostics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

co-dx.com00:00:36

See more with Sales Intelligence

Avg. pageviews on Co-Diagnostics's top domains

See how Co-Diagnostics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

co-dx.com1.87

See more with Sales Intelligence

Co-Diagnostics top competitors by domain

Top similar sites in May 2026, ranked by their affinity

biofiredx.comCompany NameBioFire Diagnostics, LLCEmployees1001 - 5000HQUnited States, Utah, Salt Lake CityAnnual revenue$200M - $500MTotal visits25.3KJobs and Career > Jobs and Career - Other

Top technologies used by Co-Diagnostics

These are the website technologies, by industry, used by Co-Diagnostics top domains

Content Management System (4)

WordPress

Widget (4)

Twemoji

Mobile (2)

Meta Viewport

Social (2)

Instagram

More Technologies

7

See all

News & Signals from Co-Diagnostics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCo-Dx, Co attended event Medical Korea 2026 on Mar 19th '26.SALT LAKE CITY, March 16, 2026 /PRNewswire/ - Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that Co-Dx will accompany World Trade Center (WTC) Utah, the Utah Governor's Office of Economic Opportunity (GOEO), BioUtah, and other legislative and industry leaders at Medical Korea 2026, taking place March 19-22 in Seoul, South Korea.

NewsCo-Dx, Co attended event The Union World Conference on Nov 20th '25.Co-Diagnostics (Nasdaq: CODX) addressed tuberculosis testing adoption at The Union World Conference on Lung Health on Nov 20, 2025 in Copenhagen.

NewsCo-Dx, Co received financing of $7M in registered direct offering on Oct 29th '25.Co-Diagnostics, Inc. announces closing of $7.0 million registered direct offering of common stock priced at-the-market under nasdaq rules.